The most recent post on this is #msg-67293937, which is from Sep 2011 and hence is out of date in two respects: i) it overstates the value of the Copaxone partnership; and ii) it predates the BAX FoB partnership. These are offsetting changes/omissions, so the bottom-line figure in #msg-67293937probably hasn’t changed that much. (Note that #msg-67293937 excludes Lovenox entirely.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”